Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Danaher Corporation. A complete text table follows the diagram.
Consumables, services and replacement cycles dominate a portfolio spanning diagnostics, bioprocessing and laboratory science, creating durability beyond equipment sales
Swipe to explore
Every monetary flow is directly reported. Financing and other expense combines reported $63M interest expense and $73M other nonoperating expense.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Recurring revenue | 1 | $5.0B | 84.5% of revenue |
| Equipment & nonrecurring revenue | 1 | $920M | Systems and capital equipment |
| Revenue | 2 | $6.0B | Life-science and diagnostics platform |
| Gross profit | 3 | $3.6B | 60.3% gross margin |
| Cost of sales | 3 | $2.4B | Manufacturing and service delivery |
| Operating income | 4 | $1.3B | 22.6% operating margin |
| Selling, general & administrative | 4 | $1.9B | Global commercial and corporate platform |
| Research & development | 4 | $387M | Science and instrument innovation |
| Interest income | 4 | $27M | Cash portfolio |
| Operating plus interest income | 5 | $1.4B | Before financing and other expense |
| Income before tax | 6 | $1.2B | 20.8% of revenue |
| Interest & other expense | 6 | $136M | Financing and nonoperating items |
| Net income | 7 | $1.0B | $1.45 diluted EPS |
| Income tax | 7 | $206M | 16.7% effective rate |
| From | To | Value |
|---|---|---|
| Recurring revenue | Revenue | $5.0B |
| Equipment & nonrecurring revenue | Revenue | $920M |
| Revenue | Gross profit | $3.6B |
| Revenue | Cost of sales | $2.4B |
| Gross profit | Operating income | $1.3B |
| Gross profit | Selling, general & administrative | $1.9B |
| Gross profit | Research & development | $387M |
| Operating income | Operating plus interest income | $1.3B |
| Interest income | Operating plus interest income | $27M |
| Operating plus interest income | Income before tax | $1.2B |
| Operating plus interest income | Interest & other expense | $136M |
| Income before tax | Net income | $1.0B |
| Income before tax | Income tax | $206M |